We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VLRS:NYSEControladora Vuela Compania de Aviacion, S.A.B. de C.V. Analysis

Data as of 2026-07-29 - not real-time

$7.56

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its short‑term and long‑term moving averages, with RSI lingering in the lower half of its range and a MACD that has turned bearish. High beta and elevated 30‑day volatility amplify price swings, while volume remains stable. Fundamental picture: Earnings per share are negative, margins are in the red, and the balance sheet shows a substantial debt load relative to equity. Despite these headwinds, the discounted cash‑flow model suggests a price target well above the current level, implying notable upside. Sentiment: The fear‑and‑greed index registers extreme greed, reflecting strong market optimism.
Recent material news reports solid June traffic performance, highlighted by double‑digit growth in international passenger mileage and modest domestic gains, indicating demand resilience that could support revenue expansion. However, the company’s high leverage and ongoing profitability challenges temper enthusiasm, suggesting that any upside will depend on continued traffic growth and successful cost management.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • price near technical support with upside potential
  • stable trading volume supporting entry
  • recent traffic growth boosting near‑term revenue

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation indicating sizable upside
  • continued international demand driving revenue growth
  • potential for debt restructuring to improve balance‑sheet health

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • persistent profitability challenges and high leverage
  • cyclical nature of the airline industry
  • need for sustained demand recovery to justify valuation

Key Metrics & Analysis

Financial Health

Revenue Growth23.90%
Profit Margin-5.73%
P/E Ratio-74.8
ROE-117.25%
ROA0.12%
Debt/Equity5675.00
P/B Ratio12.8
Op. Cash Flow$979.8M
Free Cash Flow$496.2M
Industry P/E30.3

Technical Analysis

TrendBullish
RSI39.9
Support$7.50
Resistance$9.39
MA 20$8.17
MA 50$8.05
MA 200$7.96
MACDBearish
VolumeStable
Fear & Greed Index84.54

Valuation

Fair Value$120.09
Target Price$9.34
Upside/Downside23.52%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.75
Volatility43.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.